Prognostic assessment in patients with hepatic encephalopathy

Disease Markers

Volumn 31, Issue 3, 2011, Pages 171-179

  García Martínez, Rita ^a   Simón Talero, MacArena ^a   Córdoba, Juan ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

acute liver failure; acute on chronic liver failure; Hepatic encephalopathy; liver transplantation; prognosis

Indexed keywords

ACUTE LIVER FAILURE; ACUTE ON CHRONIC LIVER FAILURE; ARTICLE; CLINICAL ASSESSMENT TOOL; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; HEPATIC ENCEPHALOPATHY; HUMAN; HYPONATREMIA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; MODEL FOR END STAGE LIVER DISEASE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE;

EID: 81155132146     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0840     Document Type: Article

References (58)

1. J. Cordoba and B. Minguez, Hepatic encephalopathy, Semin Liver Dis 28(1) (2008), 70-80. (Pubitemid 351326534)
2. P. Ferenci, A. Lockwood, K. Mullen, R. Tarter, K. Weissenborn and A.T. Blei, Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998, Hepatology 35(3) (2002), 716-721. (Pubitemid 34183979)
3. J. Polson andW.M. Lee, AASLD position paper: the management of acute liver failure, Hepatology 41(5) (2005), 1179-1197. (Pubitemid 40593928)
4. G. Ostapowicz, R.J. Fontana, F.V. Schiodt, A. Larson, T.J. Davern, S.H. Han et al., Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States, Ann Intern Med 137(12) (2002), 947-954. (Pubitemid 35440240)
5. P. Ichai and D. Samuel, Etiology and prognosis of fulminant hepatitis in adults, Liver Transpl 14(Suppl 2) (2008), S67-S79.
6. D. Samuel and P. Ichai, Prognosis indicator in acute liver failure: Is there a place for cell death markers? J Hepatol 53(4) (2010). 593-595.
7. J.G. O'Grady, G.J. Alexander, K.M. Hayllar and R.Williams, Early indicators of prognosis in fulminant hepatic failure, Gastroenterology 97(2) (1989), 439-445. (Pubitemid 19192181)
8. J. Bernuau, A. Goudeau, T. Poynard, F. Dubois, G. Lesage, B. Yvonnet et al., Multivariate analysis of prognostic factors in fulminant hepatitis B, Hepatology 6(4) (1986), 648-651. (Pubitemid 16038182)
9. A.O. Shakil, D. Kramer, G.V. Mazariegos, J.J. Fung and J. Rakela, Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria, Liver Transpl 6(2) (2000), 163-169. (Pubitemid 30173994)
10. A.C. Anand, P. Nightingale and J.M. Neuberger, Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria, J Hepatol 26(1) (1997), 62-68. (Pubitemid 27072605)
11. S. Izumi, P.G. Langley, J. Wendon, A.J. Ellis, R.B. Pernambuco, R.D. Hughes et al., Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure, Hepatology 23(6) (1996), 1507-1511. (Pubitemid 26181234)
12. A. Castells, J.M. Salmeron, M. Navasa, A. Rimola, J. Salo, H. Andreu et al., Liver transplantation for acute liver failure: analysis of applicability, Gastroenterology 105(2) (1993),532-538. (Pubitemid 23213542)
13. J.A. Wendon and F.S. Larsen, Intracranial pressure monitoring in acute liver failure. A procedure with clear indications, Hepatology 44(2) (2006), 504-506. (Pubitemid 44214891)
14. J.M. Llovet, C. Bru and J. Bruix, Prognosis of hepatocellular carcinoma: the BCLC staging classification, Semin Liver Dis 19(3) (1999), 329-338.
15. G. D'Amico, G. Garcia-Tsao and L. Pagliaro, Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies, J Hepatol 44(1) (2006), 217-231. (Pubitemid 41772537)
16. V. Arvaniti, G. D'Amico, G. Fede, P. Manousou, E. Tsochatzis, M. Pleguezuelo et al., Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis, Gastroenterology 139(4) (2010), 1246- 1256, 1256.
17. R. Jalan and R. Williams, Acute-on-chronic liver failure: pathophysiological basis of therapeutic options, Blood Purif 20(3) (2002), 252-261. (Pubitemid 34195668)
18. D. Thabut, J. Massard, A. Gangloff, N. Carbonell, C. Francoz, E. Nguyen-Khac et al., Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure, Hepatology 46(6) (2007), 1872-1882.
19. M. Cazzaniga, E. Dionigi, G. Gobbo, A. Fioretti, V. Monti and F. Salerno, The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome, J Hepatol 51(3) (2009), 475-482.
20. M. Wehler, J. Kokoska, U. Reulbach, E.G. Hahn and R. Strauss, Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems, Hepatology 34(2) (2001), 255-261. (Pubitemid 32702337)
21. T.I. Hassanein, F. Tofteng, R.S. Brown, Jr., B. McGuire, P. Lynch, R. Mehta et al., Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis, Hepatology 46(6) (2007), 1853-1862.
22. J. Bustamante, A. Rimola, P.J. Ventura, M. Navasa, I. Cirera, V. Reggiardo et al., Prognostic significance of hepatic encephalopathy in patients with cirrhosis, J Hepatol 30(5) (1999), 890-895. (Pubitemid 29248991)
23. E. Christensen, J.J. Krintel, S.M. Hansen, J.K. Johansen and E. Juhl, Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors, Scand J Gastroenterol 24(8) (1989), 999-1006.
24. J.B. Saunders, J.R. Walters, A.P. Davies and A. Paton, A 20- year prospective study of cirrhosis, Br Med J (Clin Res Ed) 282(6260) (1981), 263-266.
25. E. Strauss, R. Tramote, E.P. Silva, W.R. Caly, N.Z. Honain, R.A. Maffei et al., Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy, Hepatogastroenterology 39(6) (1992). 542-545. (Pubitemid 23056214)
26. P. Blanc, J.P. Daures, J. Liautard, R. Buttigieg, D. Desprez, G. Pageaux et al., Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial, Gastroenterol Clin Biol 18(12) (1994), 1063-1068.
27. N.M. Bass, K.D. Mullen, A. Sanyal, F. Poordad, G. Neff, C.B. Leevy et al., Rifaximin treatment in hepatic encephalopathy, N Engl J Med 362(12) (2010), 1071-1081.
28. C.A. Stewart, M.Malinchoc,W.R.Kim and P.S.Kamath, Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease, Liver Transpl 13(10) (2007), 1366-1371. (Pubitemid 47629568)
29. M. Malinchoc, P.S. Kamath, F.D. Gordon, C.J. Peine, J. Rank and P.C. ter Borg, A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts, Hepatology 31(4) (2000), 864-871. (Pubitemid 30169932)
30. J. Cordoba, G. Olive, J. Alonso, A. Rovira, A. Segarra, M. Perez et al., Improvement of magnetic resonance spectroscopic abnormalities but not pallidal hyperintensity followed amelioration of hepatic encephalopathy after occlusion of a large spleno-renal shunt, J Hepatol 34(1) (2001), 176-178. (Pubitemid 32102573)
31. O. Riggio, C. Efrati, C. Catalano, F. Pediconi, O. Mecarelli, N. Accornero et al., High prevalence of spontaneous portalsystemic shunts in persistent hepatic encephalopathy: a casecontrol study, Hepatology 42(5) (2005), 1158-1165. (Pubitemid 43112683)
32. B.C. Sharma, P. Sharma, A. Agrawal and S.K. Sarin, Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo, Gastroenterology 137(3) (2009), 885-891.
33. I.J. Hartmann, M. Groeneweg, J.C. Quero, S.J. Beijeman, R.A. de Man, W.C. Hop et al., The prognostic significance of subclinical hepatic encephalopathy, Am J Gastroenterol 95(8) (2000), 2029-2034.
34. P.Amodio, F.Del Piccolo, E. Petteno, D.Mapelli, P.Angeli, R. Iemmolo et al., Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients, J Hepatol 35(1) (2001), 37-45. (Pubitemid 32646222)
35. M. Romero-Gomez, J. Cordoba, R. Jover, J.A. Del Olmo, M. Ramirez, R. Rey et al., Value of the critical flicker frequency in patients with minimal hepatic encephalopathy, Hepatology 45(4) (2007), 879-885. (Pubitemid 46631556)
36. M. Romero-Gomez, L. Grande and I. Camacho, Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy, Hepatology 39(4) (2004), 939-943. (Pubitemid 38428932)
37. M. Romero-Gomez, M. Jover, J.A. Del Campo, J.L. Royo, E. Hoyas, J.J. Galan et al., Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: a cohort study, Ann Intern Med 153(5) (2010), 281-288.
38. M. Guevara, M.E. Baccaro, J. Rios, M. Martin-Llahi, J. Uriz, D.A. Ruiz et al., Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration, Liver Int 30(8) (2010), 1137-1142.
39. O. Riggio, S. Angeloni, F.M. Salvatori, A. De Santis, F. Cerini, A. Farcomeni et al., Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts, Am J Gastroenterol 103(11) (2008), 2738-2746.
40. I. Les, E. Doval, R. Garcia-Martinez, M. Planas, G. Cardenas, P. Gomez et al., Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy, A randomized study, Am J Gastroenterol (2010), (in press).
41. G. Pomier-Layrargues, TIPS and hepatic encephalopathy, Semin Liver Dis 16(3) (1996), 315-320. (Pubitemid 27029880)
42. Z. Hassoun, M. Deschenes, M. Lafortune, M.P. Dufresne, P. Perreault, L. Lepanto et al., Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post- TIPS chronic hepatic encephalopathy, Am J Gastroenterol 96(4) (2001), 1205-1209. (Pubitemid 32319162)
43. G.B. Phillips, R. Schwartz, G.J. Gabuzda Jr. and C.S. Davidson, The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances, N Engl J Med 247(7) (1952), 239-246.
44. J.S. Bajaj, C.M. Schubert, D.M.Heuman, J.B.Wade, D.P.Gibson, A. Topaz et al., Persistence of cognitive impairment after resolution of overt hepatic encephalopathy, Gastroenterology 138(7) (2010), 2332-2340.
45. O. Riggio, L. Ridola, C. Pasquale, S. Nardelli, I. Pentassuglio, F. Moscucci et al., Evidence of Persistent Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy, Clin Gastroenterol Hepatol (2010).
46. K.Weissenborn, U.J. Tietge, M. Bokemeyer, B. Mohammadi, U. Bode, M.P. Manns et al., Liver transplantation improves hepatic myelopathy: evidence by three cases, Gastroenterology 124(2) (2003), 346-351. (Pubitemid 36169251)
47. F.S. Larsen, L. Ranek, B.A. Hansen and P. Kirkegaard, Chronic portosystemic hepatic encephalopathy refractory to medical treatment successfully reversed by liver transplantation, Transplant International 8(3) (1995), 246-247.
48. R.E. Tarter, J.A. Switala, A. Arria, J. Plail and D.H. Van Thiel, Subclinical hepatic encephalopathy. Comparison before and after orthotopic liver transplantation, Transplantation 50(4) (1990), 632-637. (Pubitemid 20358537)
49. S. Mechtcheriakov, I.W. Graziadei, M. Mattedi, T. Bodner, A. Kugener, H.H. Hinterhubert et al., Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation, Liver Transplantation 10 (2004), 77-83. (Pubitemid 38885897)
50. F.U. Sotil, J. Gottstein, E. Ayala, C. Randolph and A.T. Blei, Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation, Liver Transpl 15(2) (2009), 184-192.
51. R. Garcia-Martinez, A. Rovira, J. Alonso, C. Jacas,M. Simon- Talero, L. Chavarria et al., Hepatic Encephalopathy Is Associated With Posttransplant Cognitive Function and Brain Volume. Liver Transpl 2010; (in press).
52. M.R. Garcia, A. Rovira, J. Alonso, F.X. Aymerich, E. Huerga, C. Jacas et al., A long-term study of changes in the volume of brain ventricles and white matter lesions after successful liver transplantation, Transplantation 89(5) (2010), 589-594.
53. M.L. Zeneroli, G. Cioni, C. Vezzelli, S. Grandi, G. Crisi, R. Luzietti et al., Prevalence of brain atrophy in liver cirrhosis patients with chronic persistent encephalopathy. Evaluation by computed tomography, J Hepatol 4(3) (1987), 283-292. (Pubitemid 17080465)
54. L.L. Levy, Brain atrophy by computerized tomography: does brain matter matter? Hepatology 8(3) (1988), 695-696.
55. C. Harper and J. Kril, Brain atrophy in chronic alcoholic patients: a quantitative pathological study, J Neurol Neurosurg Psychiatry 48(3) (1985), 211-217. (Pubitemid 15085005)
56. A. Pfefferbaum, E.V. Sullivan, D.H. Mathalon, P.K. Shear, M.J. Rosenbloom and K.O. Lim, Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics, Alcohol Clin Exp Res 19(5) (1995), 1177-1191.
57. M. Victor, R.D. ADAMS and M. Cole, The acquired (non- Wilsonian) type of chronic hepatocerebral degeneration, Medicine (Baltimore) 44(5) (1965), 345-396.
58. M.H. Finlayson and B. Superville, Distribution of cerebral lesions in acquired hepatocerebral degeneration, Brain 104(Pt 1) (1981), 79-95. (Pubitemid 12184878)